Journal
CLINICAL NUCLEAR MEDICINE
Volume 48, Issue 2, Pages E87-E88Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/RLU.0000000000004532
Keywords
F-18-FDG; Ga-68-FAPI; endometrial carcinoma; gynecological malignancies; PET/CT
Ask authors/readers for more resources
A 60-year-old woman with clear cell endometrial carcinoma underwent neoadjuvant chemotherapy. Unable to have surgery, the patient was referred to our clinic for disease evaluation. She underwent (18)FDG PET/CT and Ga-68-FAPI-04 PET/CT scans, with Ga-68-FAPI-04 PET/CT outperforming (18)FDG PET/CT in demonstrating higher uptake in metastatic lesions.
A 60-year-old woman diagnosed with clear cell endometrial carcinoma received neoadjuvant chemotherapy. However, the patient was inoperable and referred to our clinic to evaluate the extent of the disease. The patient underwent (18)FDG PET/CT and Ga-68-FAPI (fibroblast activated protein inhibitor)-04 PET/CT scans. Ga-68-FAPI-04 PET/CT outperformed (18)FDG PET/CT demonstrating higher uptake in the metastatic lesions.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
